Joe Pantginis

Joe Pantginis has extensive experience in equity research, particularly in the biotechnology sector. Joe currently holds the role of Managing Director Equity Research at H.C. Wainwright & Co., LLC, a position they have held since 2017. Prior to this, Joe was also a Managing Director in Equity Research at Rodman & Renshaw in 2016. Joe served as a Senior Biotechnology Analyst at Roth Capital Partners from 2009 to 2016. Before that, they held the position of Senior Vice President at Merriman Curhan Ford & Co. from 2008 to 2009. Joe began their career as a Vice President at Canaccord Adams in 2005.

Joe Pantginis earned a Ph.D. in Molecular Genetics from Albert Einstein College of Medicine, where they studied from 1991 to 1998. Joe then pursued an MBA in Finance from Pace University - Lubin School of Business, which they completed between 1999 and 2001. Prior to that, they obtained a Bachelor of Science (BS) degree in Biology from Fordham University, where they studied from 1987 to 1991.